tiprankstipranks
Sequana Medical N.V (DE:2SE)
FRANKFURT:2SE
Germany Market
2SE
Sequana Medical N.V
RESEARCH TOOLSreports

Sequana Medical N.V (2SE) Ratios

18 Followers

Sequana Medical N.V Ratios

DE:2SE's free cash flow for Q2 2025 was €0.00. For the 2025 fiscal year, DE:2SE's free cash flow was decreased by € and operating cash flow was €0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Mar 22
Liquidity Ratios
Current Ratio
 0.12 0.12 0.32 1.52 1.80
Quick Ratio
 0.08 0.08 0.21 1.35 1.50
Cash Ratio
 0.07 0.07 0.13 1.25 1.34
Solvency Ratio
 -0.81 -0.81 -1.09 -1.06 -1.50
Operating Cash Flow Ratio
 -0.38 -0.38 -1.49 -1.81 -3.29
Short-Term Operating Cash Flow Coverage
 -0.51 -0.51 -3.72 -6.13 9.36
Net Current Asset Value
€ -47.91M€ -47.91M€ -23.27M€ -5.09M€ -2.60M
Leverage Ratios
Debt-to-Assets Ratio
 4.03 4.03 1.73 0.68 0.55
Debt-to-Equity Ratio
 -0.90 -0.90 -0.90 -8.17 -10.27
Debt-to-Capital Ratio
 -9.40 -9.40 -9.01 1.14 1.11
Long-Term Debt-to-Capital Ratio
 0.00 0.00 -0.85 1.21 1.12
Financial Leverage Ratio
 -0.22 -0.22 -0.52 -12.09 -18.69
Debt Service Coverage Ratio
 -0.27 -0.27 -2.45 -5.52 11.61
Interest Coverage Ratio
 -0.71 -0.71 -6.88 -31.93 -39.56
Debt to Market Cap
 0.83 0.35 0.16 0.12 0.03
Interest Debt Per Share
 1.82 1.82 0.81 0.81 0.48
Net Debt to EBITDA
 -2.09 -2.09 -0.51 0.04 0.07
Profitability Margins
Gross Profit Margin
-2092.45%-2092.45%76.95%77.83%79.31%
EBIT Margin
-16989.62%-16989.62%-4141.05%-3252.10%-6116.60%
EBITDA Margin
-16409.43%-16409.43%-4091.26%-3164.05%-6002.90%
Operating Profit Margin
-17647.17%-17647.17%-4141.05%-3044.86%-6113.17%
Pretax Profit Margin
-41861.32%-41861.32%-4507.05%-3292.17%-6267.69%
Net Profit Margin
-42126.42%-42126.42%-4572.42%-3334.08%-6373.84%
Continuous Operations Profit Margin
-42125.47%-42125.47%-4572.42%-3334.08%-6373.84%
Net Income Per EBT
100.63%100.63%101.45%101.27%101.69%
EBT Per EBIT
237.21%237.21%108.84%108.12%102.53%
Return on Assets (ROA)
-449.05%-449.05%-322.38%-118.20%-160.59%
Return on Equity (ROE)
139.88%100.62%167.29%1428.68%3000.95%
Return on Capital Employed (ROCE)
43.23%43.23%314.93%-258.29%-300.98%
Return on Invested Capital (ROIC)
540.85%540.85%2308.34%-179.32%-428.48%
Return on Tangible Assets
-449.05%-449.05%-322.38%-118.20%-160.59%
Earnings Yield
-199.67%-39.87%-30.41%-22.52%-17.15%
Efficiency Ratios
Receivables Turnover
 0.35 0.35 16.53 2.27 0.97
Payables Turnover
 0.01 0.01 0.06 0.06 0.03
Inventory Turnover
 0.01 0.01 0.07 0.08 0.04
Fixed Asset Turnover
 0.06 0.06 0.31 0.45 0.29
Asset Turnover
 0.01 0.01 0.07 0.04 0.03
Working Capital Turnover Ratio
 >-0.01 >-0.01 -0.27 0.14 0.06
Cash Conversion Cycle
 3.20K 3.20K -958.55 -920.58 122.83
Days of Sales Outstanding
 1.04K 1.04K 22.08 160.69 377.44
Days of Inventory Outstanding
 28.24K 28.24K 5.11K 4.68K 10.19K
Days of Payables Outstanding
 26.07K 26.07K 6.09K 5.76K 10.44K
Operating Cycle
 29.28K 29.28K 5.13K 4.84K 10.56K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.56 -0.56 -1.09 -1.21 -1.30
Free Cash Flow Per Share
 -0.56 -0.56 -1.11 -1.24 -1.31
CapEx Per Share
 <0.01 <0.01 0.03 0.03 0.02
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.02 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
 -214.95 -214.95 -40.89 -40.61 -72.49
Capital Expenditure Coverage Ratio
 -214.95 -214.95 -40.89 -40.61 -72.49
Operating Cash Flow Coverage Ratio
 -0.51 -0.51 -1.66 -1.56 -2.92
Operating Cash Flow to Sales Ratio
 -192.64 -192.64 -40.81 -29.78 -63.74
Free Cash Flow Yield
-42.95%-18.32%-27.80%-20.61%-17.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.50 -2.51 -3.29 -4.44 -5.83
Price-to-Sales (P/S) Ratio
 450.60 1.06K 150.38 148.06 371.63
Price-to-Book (P/B) Ratio
 -0.50 -2.52 -5.50 -63.45 -174.97
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.33 -5.46 -3.60 -4.85 -5.75
Price-to-Operating Cash Flow Ratio
 -1.10 -5.48 -3.68 -4.97 -5.83
Price-to-Earnings Growth (PEG) Ratio
 0.01 0.00 0.34 -1.15 -1.46
Price-to-Fair Value
 -0.50 -2.52 -5.50 -63.45 -174.97
Enterprise Value Multiple
 -4.83 -8.53 -4.19 -4.64 -6.12
Enterprise Value
 84.07M 148.31M 122.03M 135.33M 136.17M
EV to EBITDA
 -4.83 -8.53 -4.19 -4.64 -6.12
EV to Sales
 793.09 1.40K 171.35 146.67 367.54
EV to Free Cash Flow
 -4.10 -7.23 -4.10 -4.81 -5.69
EV to Operating Cash Flow
 -4.12 -7.26 -4.20 -4.92 -5.77
Tangible Book Value Per Share
 -1.21 -1.21 -0.73 -0.09 -0.04
Shareholders’ Equity Per Share
 -1.21 -1.21 -0.73 -0.09 -0.04
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 -0.01 -0.01 -0.02
Revenue Per Share
 <0.01 <0.01 0.03 0.04 0.02
Net Income Per Share
 -1.22 -1.22 -1.22 -1.35 -1.30
Tax Burden
 1.01 1.01 1.01 1.01 1.02
Interest Burden
 2.46 2.46 1.09 1.01 1.02
Research & Development to Revenue
 15.88 15.88 7.41 8.35 16.57
SG&A to Revenue
 155.55 155.55 9.75 7.25 13.76
Stock-Based Compensation to Revenue
 -1.69 -1.69 0.79 0.61 1.45
Income Quality
 0.46 0.46 0.89 0.89 1.00
Currency in EUR